Crinetics Pharmaceuticals
Latest round
- Series B
Last raised
- Feb 2018
Total raised
- $105M
Investors
- 6
About Crinetics Pharmaceuticals
Founded in 2008 and based in California, US, Crinetics Pharmaceuticals Inc. is a pharmaceutical company that manufactures and distributes medical drugs for endocrine diseases and cancer. These drugs include an oral selective nonpeptide somatostatin receptor type 2 biased agonist, a treatment for acromegaly; an oral selective nonpeptide somatostatin type 5 receptor agonist, a treatment for congenital hyperinsulinism; and an oral, selective nonpeptide sst2 biased agonist, a treatment for neuroendocrine tumors.
Who invested in Crinetics Pharmaceuticals
6 investors across 2 rounds
See all investors in Crinetics Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Crinetics Pharmaceuticals
Who invested in Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Crinetics Pharmaceuticals raised?
Crinetics Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Crinetics Pharmaceuticals last raise money?
Crinetics Pharmaceuticals's most recent round on record is a Series B, in Feb 2018.
What does Crinetics Pharmaceuticals do?
Founded in 2008 and based in California, US, Crinetics Pharmaceuticals Inc.
Where is Crinetics Pharmaceuticals headquartered?
Crinetics Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Crinetics Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Crinetics Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Crinetics Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.